Share >  
Share
Share on Tumblr

Natco Pharma Ltd

News »

   latest by relevance
Capacity debottlenecking led to growth: Shasun Pharma
May 25, 2012 at 15:54 | Source: CNBC-TV18
Abhaya Kumar, managing director, Shasun Pharmaceuticals Ltd says that capacity debottlenecking and higher customer demand contributed to 40% y-o-y growth. He also says that the company expects 25% growth in EPS of the company in FY13.
Aventis Pharma renamed as Sanofi India
May 16, 2012 at 16:33 | Source: PTI
Sanofi Group's listed entity in India, today announced that the Registrar of Companies had approved the company's change of name from Aventis Pharma Ltd to 'Sanofi India Ltd', with effect from May 11.
PATENTS OR PATIENTS?
May 09, 2012 at 16:10 | Source: Moneycontrol.com
By: Vikas Dandekar, PharmaAsia News
Cancer drug wars! Cipla slashes prices
May 04, 2012 at 13:45 | Source: CNBC-TV18
It's a drug war, but with a difference and it's been kicked off by Cipla. CNBC TV18's Archana Shukla reports that country's second largest drug firm has slashed prices of three of its key cancer drugs by more than half, making cancer medication costs come down by over 50%.
Cipla's price cut is strategic move: Expert
May 04, 2012 at 13:01 | Source: CNBC-TV18
Cipla's move to slash price of its cancer drug by almost 75% is a strong one, this is not only a humanitarian move, but is a strategic play as well, Vikas Dandekar of Pharmasianews.com told CNBC-TV18.
Bull's Eye: Buy Titan, Bajaj Finserv, Tata Coffee
Apr 28, 2012 at 14:35 | Source: Moneycontrol.com
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

Videos »
Capacity debottlenecking led to growth: Shasun Pharma
Cipla's price cut is strategic move: Expert
Cancer drug wars! Cipla slashes prices
Bull's Eye: Buy Titan, Bajaj Finserv, Tata Coffee
Exit from Natco Pharma, says Aashish Tater
more »

Photos »

  /  
News across the web »
Biotech body criticises Bayer on cancer drug
Hyderabad, May 12: The All India Biotech Association – Southern Chapter (AIBA-SC) has come out strongly in favour of the Indian Patents Office order in favour of Natco Pharma Ltd. In a statemen...
May 12, 2012 at 22:36 | Source: The Hindu BusinessLine
Nifty seen opening lower on weak global cues; HDFC eyed
NEW DELHI: The 50-share Nifty index is expected to open lower on Monday following sharp sell-off on Wall St after a slowdown in job creation in the world's top economy raised fuelled concerns about t...
May 07, 2012 at 08:26 | Source: Economic Times
Natco Pharma bags Golden Peacock
Natco Pharma Ltd has bagged the Golden Peacok Award for corporate social responsibility for the year 2012. The award was presented to the Hyderabad-based company at a function held in Dubai on Wednes...
Apr 28, 2012 at 02:10 | Source: The Hindu BusinessLine
Don't shut door on cheap drugs
One industry that, arguably, did not feel the effects of the global slowdown, or inflationary pressures, was pharmaceuticals. Several forecasts and studies have projected a robust growth for the sect...
Apr 23, 2012 at 23:27 | Source: The Hindu BusinessLine
Patent disregard for patients
March 13, 2012: It is perhaps, very rare to see a class action — of a different kind, though. One has heard of class action suits filed by shareholders against corporates, accusing fraud and ma...
Mar 14, 2012 at 03:08 | Source: The Hindu BusinessLine
more »
Interact & exchange stock tips & market info »

India_bulls

Platinum Member

5308 Followers

Techtran Polyle  

in Future. Its a Multibagger stock. Just buy and hold 1 year will get...

5.24 PM Apr 30th

India_bulls

Platinum Member

5308 Followers

Just Posted  

in Future. Its a Multibagger stock. Just buy and hold 1 year will get...

2.20 PM Apr 30th

MMB Messenger

Platinum Member

112443 Followers

Natco Pharma  

Natco Pharma Ltd has informed BSE regarding a Pre...

4.38 PM Apr 17th

Related News »
Compulsory licensing sets off a wave of price cuts in cancer drugs
Mumbai: Prices of cancer medicines are dropping dramatically after India allowed Hyderabad’s Natco Pharma Ltd to sell a copy of German firm Bayer AG’s patented cancer drug Nexavar under compulsory licensing norms. Natco has started selling its copy of ...
May 8, 2012 at 18:04 | Source: Livemint.com
India: Compulsory License Granted To NATCO
On March 9, 2012, the Indian generic pharmaceutical industry got a shot in the arm when Indian Patent Office, by invoking the compulsory license (CL) provisions of the Patents Act, allowed NATCO PHARMA LTD, an Indian generic drug manufacturer to ...
May 15, 2012 at 04:34 | Source: Mondaq
Indian market indices open in green
... the day on a mixed note with Natco Pharma and Aurobindo Pharma trading firm. However, Indoco Remedies and J B Chemicals are facing selling pressure. As per a leading financial daily, Indian drug manufacturer Lupin Ltd is voluntarily recalling 10,800 ...
May 24, 2012 at 14:53 | Source: MSN India
India, US see differences widen over trade, diplomatic issues
The US has also raised concern over India allowing Hyderabad-based Natco Pharma Ltd to manufacture and market a copy of Bayer AG’s liver and kidney cancer drug nexavar—the first time a local firm was granted the so-called compulsory licence.
May 13, 2012 at 18:12 | Source: Livemint.com
Cancer: Big in the city
Last week, Swiss-based Roche Holding AG and Cipla Ltd announced they will be lowering prices for five of their expensive cancer-fighting drugs after Hyderabad’s Natco Pharma Ltd started selling a copy of German firm Bayer AG’s patented cancer drug ...
May 11, 2012 at 05:00 | Source: Express Buzz

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window